These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
6. [More transparency facilities drug choice in general practice. Booster regimens in direct comparison]. MMW Fortschr Med; 2002 Apr; 144 Suppl 1():82. PubMed ID: 12043090 [No Abstract] [Full Text] [Related]
7. Update from the 5th Conference on Retroviruses and Opportunistic Infections. Vazquez E Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483 [TBL] [Abstract][Full Text] [Related]
8. Head-to-head study of protease inhibitors. AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890 [No Abstract] [Full Text] [Related]
9. Protease inhibitor combos. Newsline People AIDS Coalit N Y; 1998 Feb; ():36-7. PubMed ID: 11367448 [TBL] [Abstract][Full Text] [Related]
10. Twice-a-day Crixivan study discontinued. Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up. Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062 [TBL] [Abstract][Full Text] [Related]
13. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
14. Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study). Florence E; Dreezen C; Desmet P; Smets E; Fransen K; Vandercam B; Pelgrom J; Clumeck N; Colebunder R Antivir Ther; 2001 Dec; 6(4):255-62. PubMed ID: 11878407 [TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor update. Colvin R; Haas G Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340 [TBL] [Abstract][Full Text] [Related]
16. Saquinavir (Fortovase or Invirase). Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182 [No Abstract] [Full Text] [Related]
17. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy. Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718 [TBL] [Abstract][Full Text] [Related]
19. More clinical data on protease inhibitors. Smart T GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917 [TBL] [Abstract][Full Text] [Related]
20. Why the old saquinavir (Invirase) may be bad for your health. Vazquez E Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]